Page last updated: 2024-12-11
diaporthin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
diaporthin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5323561 |
CHEMBL ID | 4163739 |
MeSH ID | M0402545 |
Synonyms (16)
Synonym |
---|
6512-79-4 |
diaporthin |
8-hydroxy-3-[(2s)-2-hydroxypropyl]-6-methoxyisochromen-1-one |
(s)-8-hydroxy-3-(2-hydroxypropyl)-6-methoxy-1h-2-benzopyran-1-one |
348g93mx9z , |
unii-348g93mx9z |
10532-39-5 |
1h-2-benzopyran-1-one, 8-hydroxy-3-(2-hydroxypropyl)-6-methoxy-, (s)- |
isocoumarin, 8-hydroxy-3-(2-hydroxypropyl)-6-methoxy-, (+)- |
8-hydroxy-3-(2-hydroxy-propyl)-6-methoxy-isochromen-1-one, (+)- |
8-hydroxy-3-(2-hydroxy-propyl)-6-methoxy-isochromen-1-one, (s)- |
ncgc00384779-01!8-hydroxy-3-[(2s)-2-hydroxypropyl]-6-methoxyisochromen-1-one |
Q27256349 |
DTXSID60909444 |
8-hydroxy-3-(2-hydroxypropyl)-6-methoxy-1h-2-benzopyran-1-one |
CHEMBL4163739 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (7)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1354809 | Cytotoxicity against human MCF7 cells by MTT assay | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 | Peniisocoumarins A-J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. |
AID1354806 | Cytotoxicity against human A549 cells by MTT assay | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 | Peniisocoumarins A-J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. |
AID1354807 | Cytotoxicity against human HepG2 cells by MTT assay | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 | Peniisocoumarins A-J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. |
AID1354810 | Cytotoxicity against human HEK293T cells by MTT assay | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 | Peniisocoumarins A-J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. |
AID1354808 | Cytotoxicity against human HeLa cells by MTT assay | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 | Peniisocoumarins A-J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. |
AID1354802 | Inhibition of Saccharomyces cerevisiae alpha-glucosidase at 200 uM using p-nitrophenyl-glycoside as substrate incubated for 20 mins followed by substrate addition measured immediately relative to control | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 | Peniisocoumarins A-J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. |
AID1354805 | Inhibition of Mycobacterium tuberculosis H37Ra PTPB expressed in Escherichia coli BL21 (DE3) at 50 uM using p-nitrophenyl phosphate as substrate preincubated for 10 mins followed by substrate addition measured for 5 mins by spectrophotometric analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 | Peniisocoumarins A-J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.63
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.63) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |